DHDheya Abdull Hameed

Dheya Abdull Hameed

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dheya Abdull Hameed has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association of Khat chewing and shisha smoking with metabolic syndrome and diabetes factors among Yemeni women

    by Dheya Abdull Hameed, Maher Ali Almaqtari, Mona Abdullah Al-Tahami, Riyadh Saif-Ali, Saad Al-Arnoot

    Khat chewing and shisha smoking have spread among women in Yemeni society; thereby, these modifiable lifestyles may contribute to the development of metabolic syndrome. Therefore, this study aimed to investigate the association of Khat chewing and combined shisha smoking and Khat chewing with metabolic syndrome factors among Yemeni females. An analytical cross-sectional study was conducted. One hundred and eighty Yemeni females signed the consent form and donated blood; 60 of them were non-smoking non-Khat chewers (control group), 60 were non-smoking Khat chewers, and 60 were shisha-smoking Khat chewers. Analysis of covariance (ANCOVA) showed that Khat chewing was associated with higher triglycerides (TG) (p = 0.001) and waist circumference (p = 0.001) in non-smoking Khat chewers compared with non-smoking non-Khat chewer women. In addition, ANCOVA showed that TG is an important covariate associated with insulin resistance among khat-chewing women. In conclusion, Khat chewing is associated with a higher risk of metabolic syndrome and type 2 diabetes mellitus in Yemeni females.

  • Open Access

    Synthesis, Spectroscopic Characterization, and Antibacterial Evaluation of Novel Organophosphorus Schiff Base Derivatives Derived from Chlorodiphenylphosphine

    by Dheya A. Hameed, Fathi M. Al-Azab, Yasmin M.S. Jamil, Nedhal A.A. Al-Selwi, Gamil M.S. Qasem

    In this study, three novel organophosphorus Schiff base derivatives (OPC1–OPC3) were successfully synthesized by condensing chlorodiphenylphosphine with different Schiff bases derived from various aldehydes and hydrazine derivatives. The structural elucidation of the synthesized compounds was achieved using comprehensive spectroscopic analyses, including FTIR, UV-Vis, and both 1H and 13C NMR spectroscopy. Elemental analysis and physical property measurements further confirmed the proposed molecular structures. Spectroscopic data revealed characteristic azomethine (C=N), phosphorus–carbon (P–C), and phosphorus oxygen (P–O–C) stretching bands, confirming the successful formation of the organophosphorus Schiff base framework. The synthesized compounds were tested for antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus using the agar well diffusion method. The results demonstrated that all compounds exhibited moderate to significant antibacterial activity, with OPC2 and OPC3 showing notable inhibition zones compared to OPC1. These findings suggest that the incorporation of organophosphorus moieties into Schiff base ligands enhances their biological potency and provides a promising route for developing new bioactive organophosphorus materials.

  • Open Access

    From Synthesis to Bioactivity: A Ti(IV)-Coordinated Phosphorylated Schiff Base System with XRD-Validated Structure and Enhanced Efficacy Against Multidrug-Resistant Bacterial Pathogens

    by Dheya A. Hameed, Nedhal A. A. Al-Selwi, Fathi M. Al-Azab, Yasmin M.S. Jamil, Ahmed N Alhakimi, Gamil M.S. Qasem, Thamer Alorini, Abuzar E. A. Albadri

    A novel organophosphorus Schiff base ligand, diphenyl (2-((2-phenylhydrazineylidene)methyl)phenyl) phosphate (OPSBL), was synthesized through the reaction of 2-(2-phenylhydrazineylidene)methyl phenol with diphenylchlorophosphate. Its Ti(IV) complex, [Ti(OPSBL)Cl₂]Cl₂·2H₂O, was prepared in a 1:2 molar ratio (metal: ligand) and characterized via IR, UV-Vis, ¹H/¹³C NMR, XRD, and elemental analysis. The complex exhibited electrolytic behavior, as confirmed by molar conductance measurements (134.18 Ω⁻¹ cm² mol⁻¹). XRD analysis revealed reduced crystallinity (41%) and smaller particle size (~300 nm) compared to the ligand, attributed to structural disarray and disrupted intermolecular interactions upon metal coordination. Molecular docking studies against Staphylococcus aureus (4URM), Bacillus subtilis (2RHL), and Escherichia coli (4PRV) demonstrated strong binding affinities (−6.00 to −6.52 kcal/mol), particularly targeting resistance-associated enzymes. Antibacterial assays against multidrug-resistant pathogens showed superior inhibitory activity for the Ti(IV) complex vs. the free ligand (25 mm vs. 18 mm at 300 µg/mL against E. coli. These findings highlight the potential of Ti(IV)-Schiff base systems as a preliminary indication of multi-target potential against resistant bacterial infections, combining structural stability with bioactivity. Further studies on cytotoxicity and single-crystal validation are warranted.